NYSE:PRGO - New York Stock Exchange, Inc. - IE00BGH1M568 - Common Stock - Currency: USD
We assign a fundamental rating of 5 out of 10 to PRGO. PRGO was compared to 195 industry peers in the Pharmaceuticals industry. There are concerns on the financial health of PRGO while its profitability can be described as average. PRGO scores decently on growth, while it is valued quite cheap. This could make an interesting combination. PRGO also has an excellent dividend rating.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -1.85% | ||
ROE | -4.13% | ||
ROIC | 3.66% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 9.28% | ||
PM (TTM) | N/A | ||
GM | 36.38% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.82 | ||
Debt/FCF | 20.03 | ||
Altman-Z | 0.84 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 2.36 | ||
Quick Ratio | 1.28 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 9.27 | ||
Fwd PE | 8.01 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | 20.05 | ||
EV/EBITDA | 9.4 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 4.41% |
NYSE:PRGO (6/24/2025, 11:49:34 AM)
26.6075
+0.16 (+0.6%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 4.41% |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 9.27 | ||
Fwd PE | 8.01 | ||
P/S | 0.84 | ||
P/FCF | 20.05 | ||
P/OCF | 12.11 | ||
P/B | 0.83 | ||
P/tB | N/A | ||
EV/EBITDA | 9.4 |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -1.85% | ||
ROE | -4.13% | ||
ROCE | 4.63% | ||
ROIC | 3.66% | ||
ROICexc | 3.84% | ||
ROICexgc | 13.02% | ||
OM | 9.28% | ||
PM (TTM) | N/A | ||
GM | 36.38% | ||
FCFM | 4.18% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.82 | ||
Debt/FCF | 20.03 | ||
Debt/EBITDA | 4.94 | ||
Cap/Depr | 36.59% | ||
Cap/Sales | 2.74% | ||
Interest Coverage | 250 | ||
Cash Conversion | 41.27% | ||
Profit Quality | N/A | ||
Current Ratio | 2.36 | ||
Quick Ratio | 1.28 | ||
Altman-Z | 0.84 |